Q32 Bio
QTTB
QTTB
87 hedge funds and large institutions have $49.9M invested in Q32 Bio in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
44% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 34
44% less capital invested
Capital invested by funds: $89.6M → $49.9M (-$39.7M)
97% less call options, than puts
Call options by funds: $36K | Put options by funds: $1.1M
Holders
87
Holding in Top 10
1
Calls
$36K
Puts
$1.1M
Top Buyers
| 1 | +$1.42M | |
| 2 | +$1.21M | |
| 3 | +$552K | |
| 4 |
Citigroup
New York
|
+$426K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$388K |
Top Sellers
| 1 | -$4.36M | |
| 2 | -$1.68M | |
| 3 | -$952K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$848K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$775K |